Drugs for Rare Diseases: Influence of Orphan Designation Status on Price

By Picavet Eline  

Applied Health Economics and Health Policy, Vol. 9, Iss. 4, 2011-07 ,pp. : 275-279

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness of School Support for Orphan Girls to Prevent HIV Infection in Zimbabwe

By Miller Ted   Hallfors Denise   Cho Hyunsan   Luseno Winnie   Waehrer Geetha  

Prevention Science, Vol. 14, Iss. 5, 2013-10 ,pp. : 503-512

Springer Publishing Company

Access to resources Recommend Favorite

Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007

By Orofino Javier  

Applied Health Economics and Health Policy, Vol. 8, Iss. 5, 2010-09 ,pp. : 301-315

Adis International

Access to resources Recommend Favorite

Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?

By Asten Liselotte   Zangerle Robert   Hernández Aguado Ildefonso   Boufassa Faroudy   Broers Barbara   Brettle Raymond   Roy Robertson J.   McMenamin Jim   Coutinho Roel   Prins Maria  

European Journal of Epidemiology, Vol. 20, Iss. 9, 2005-09 ,pp. : 795-804

Springer Publishing Company

Access to resources Recommend Favorite

Practical and philosophical issues surrounding a national item bank: if we build it will they come?

By Revicki Dennis   Sloan Jeff  

Quality of Life Research, Vol. 16, Iss. 1, 2007-08 ,pp. : 167-174

Springer Publishing Company

Access to resources Recommend Favorite